AML highlights from ASH 2017
New endpoints in clinical trials to better serve patients
Elihu H. Estey
PEP-C for lymphoma palliative care: a regional experience in the UK
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?
iNNOVATE results: a prospective new standard of care for Waldenström’s